1)coagulation and fibrinolysis dynamicogram凝血-纤溶动态图
1.Utility of coagulation and fibrinolysis dynamicogram for detection of imbalance between coagulation and fibrinolysis in patient with sepsis;凝血-纤溶动态图在脓毒症凝血纤溶失衡检测中的应用
2)coagulation and fibrinolysis dynamic-pattern凝血-纤溶图
3)Coagulation and fibrinolysis dynamic balance凝血-纤溶动态平衡
英文短句/例句
1.Influence of HES on coagulation-fibrinolysis system during perioperative stage围术期输注羟乙基淀粉对凝血-纤溶动态平衡的影响
2.Effect of thoracic epidural analgesia on coagulation and fibrinolysis dynamic balance in patients undergoing major thoracic surgery胸段硬膜外镇痛对胸科手术患者凝血-纤溶动态平衡的影响
3.Pulmonary Thromboembolism and the Disturbances of Coagulation and Fibrinolysis;肺动脉血栓栓塞症与凝血纤溶系统失衡
4.A Correlative Study of Coagulation、Fibrinolitic System and Cerebral Vasospasm、Rebleeding in Subarachoid Haemorrhage;SAH患者凝血及纤溶动态变化与迟发性血管痉挛、再出血的相关研究
5.Preliminary application of coagulation - fibrinolysis dynamicogram detector in the CPB anticoagulation monitor血凝-纤溶动态检测仪在体外循环抗凝检测中的初步应用
6.Dynamic monitoring the diagnosis value of D-Dimer and Coagulation-fibrinolysis parameter on deep venous thrombosis动态监测D-二聚体及凝血-纤溶参数对深静脉血栓的意义
7.Role of the coagulation and fibrinolysis in acute lung injury凝血和纤溶失衡在急性肺损伤中的作用
8.Effects of Different Levels of Testosterone on Coagulative and Fibrinolytic System;雄激素水平变化对血液凝血和纤溶系统的影响
9.Dynamic Changes of Coagulation、Fibrinolysis and Mediators of Inflammation in the Blood of Patients with CVS after Subarachnoid Hemorrhage;蛛网膜下腔出血继发脑血管痉挛患者凝血纤溶和炎症介质的动态变化研究
10.Coagulation and Fibrinolysis in Patients with Coronary Heart Disease and Clinical Significance of Changes in State冠心病患者凝血纤溶状态改变及其临床意义
11.Changes of fibrinolytic status and coagulation function of peripheral blood at the acute stage in patients with intracerebral hemorrhage脑出血患者急性期外周血纤溶状态及凝血功能的变化
12.Coagulation-fibrinolysis Activation in Patients with Binswangerdisease;皮质下动脉硬化性脑病的凝血纤溶变化
13.Effects of Acute Exercise on Blood Conagulation and Fibrinolysis;急性运动对血液凝固和纤维蛋白溶解的影响
14.A Study on Relationship between Serum Lipoprotein(a) Level, The Changes of Plasma Haemostatic and Fibrinolytic Activities and T2 Diabetic Nephropathy;血清脂蛋白（a）水平和凝血纤溶的改变与2型糖尿病肾病关系的研究
15.Effects of Angiotensin Ⅱ and Captopril, Valsartan on the Fibrinolytic Banlance of Human Umbilical Vein Endothelial Cells;血管紧张素Ⅱ及抗RAS药对人脐静脉内皮细胞纤溶平衡的影响
16.Effects of Valsartan and Perindopril on Fibrinolytic Balance in Patients with Hypertension and Diabetes Mellitus;缬沙坦和培哚普利对高血压合并糖尿病患者纤溶平衡的影响
17.Effects of Cigarette Smoke Extract and Simvastatin on the Expression of T-PA and PAI-1 in Cultured Human Umbilical Vein Endothelial Cell香烟提取物及辛伐他汀对血管内皮细胞纤溶平衡的影响
18.Explorative research on the dynamic dissolution equilibrium in the carbon dioxide-water system二氧化碳-水体系动态溶解平衡的探索性研究
相关短句/例句
coagulation and fibrinolysis dynamic-pattern凝血-纤溶图
3)Coagulation and fibrinolysis dynamic balance凝血-纤溶动态平衡
4)coag凝血/纤溶
1.Effect of Maiditong for injection on coagulative and fibrionlytic system in diabetic nephropathy;迈地通对2型糖尿病肾病凝血/纤溶状态的影响
5)fibrinolysis factors凝血纤溶
1.Objective The aim of this study is to explore the expressions of blood coagulative fibrinolysis factors, (FRA、FN、α2-PI、PLG) in the mechanism of human glomerulonephritis and their correlation, and the accelerative effects in glomeruli cirrhosis.目的 探讨凝血纤溶因子(FRA、FN、α_2-PI、PLG)在原发性肾小球肾炎中的表达及差异,分析各因子之间的相互关系及其促使肾小球硬化的作用机理。
6)Blood coagulation-fibrinolysis凝血-纤溶
延伸阅读
凝血致活酶 ,血液凝固因子Ⅲ,凝血质药物名称：凝血因数Ⅲ英文名：Thromboplastin别名： 凝血活素;凝血酶原激酶;凝血因数Ⅲ;凝血致活酶 ,血液凝固因子Ⅲ,凝血质 外文名：Thromboplastin 适应症： 用于各种出血、止血。 用量用法： 肌注：每次７．５～１５ｍｇ,Qd或Bid。局部止血时可湿敷。 注意事项： 1.肌注以前要摇匀。 2.不可静注（可引起血栓形成）。 规格： 注射液：１５ｍｇ（２ｍｌ）。 类别：促凝血药
